LEADER 03214nam  2200817z- 450 
001 9910557396203321
005 20231214133041.0
035   $a(CKB)5400000000041935
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69436
035   $a(EXLCZ)995400000000041935
100   $a20202105d2020      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aIon Channels as Marine Drug Targets
210   $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020
215   $a1 electronic resource (134 p.)
311   $a3-03943-797-6 
311   $a3-03943-798-4 
330   $aMarine Drugs is glad to announce its first Special Issue book on ?ion channels? related research: Under the great stewardship of the Guest Editor, Dr. Jean-Marc Sabatier, four advanced research articles and three comprehensive review papers were collected in the Special Issue ?Ion Channels as Marine Drug Targets?. Join us to explore the advanced research outcomes in this field: ?-Conotoxin RgIA and a potent analog, RgIA4, in treatment of pain; botulinum toxin-chitosan nanoparticles in treatment of atrial fibrillation; 27-amino acid (aa)-long ?-conotoxin TxVIA that modulates mammalian CaV3.x; first venomics study of Conus tulipa venom; review on marine toxins targeting Kv1 channels; review on synthetic approaches to zetekitoxin AB; and review on marine natural products and drug resistance in latent tuberculosis. The second edition of this Special Issue is open for submissions, we look forward to your contribution.
606   $aMedicine$2bicssc
610   $aconotoxin
610   $aConus tulipa
610   $aintraspecific variation
610   $avenomics
610   $atranscriptomics
610   $aproteomics
610   $aconantokins
610   $anet hunting strategy
610   $anirvana cabal
610   $aion channel modulators
610   $amarine anti-TB compounds
610   $aPZA
610   $aMTB
610   $alatent TB
610   $asponges
610   $anicotinic
610   $achemotherapy
610   $apaclitaxel
610   $ataxane
610   $aneuropathic pain
610   $a?9?10
610   $asaxitoxin
610   $azetekitoxin AB
610   $avoltage-gated sodium channel
610   $aguanidine alkaloid
610   $abioactives
610   $aconotoxins 2
610   $aKv1
610   $amarine toxins
610   $amodulators
610   $apotassium channels
610   $asea anemone toxins
610   $aTxVIA
610   $amammalian NaV channel
610   $aselective inhibitor
610   $aT-type CaV3.2
610   $abotulinum toxin A1
610   $achitosan nanoparticles
610   $aantiarrhythmics
610   $apharmacological models of arrhythmia
610   $aelectrically induced arrhythmia
615  7$aMedicine
700   $aSabatier$b Jean-Marc$4edt$01295534
702   $aSabatier$b Jean-Marc$4oth
906   $aBOOK
912   $a9910557396203321
996   $aIon Channels as Marine Drug Targets$93023587
997   $aUNINA